Lokon Pharma AB
556871-2292ActiveDeveloping novel gene engineering vectors for cancer immunotherapy.
Biotechnology Companylokonpharma.com
Yleiskatsaus
- 10–19
- Työntekijät
- 1–49t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Linda Sandin
Head of Data Science and Operations
Emma Eriksson
Head of R&D
Erika Kjellberg Eriksson
Chair of the Board
Titti Björnström
Head of Quality Assurance & Quality Control
+3 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Lokon Pharma is a Swedish biotechnology company dedicated to pioneering next-generation cancer immunotherapeutics. They specialize in developing tumor microenvironment (TME) gene engineering vectors utilizing their proprietary LOAd technology. This technology employs oncolytic viruses, derived from...